A study performed in patients with BC showed that less elevated kisspeptin expression was associated with a negative prognostic factor for overall survival, axillary lymph node status, metastatic propensity, advancing tumor stage, and advanced grade [121]. This evidence concerns the gene KISS1 and neoplasm.